Research Article
Serum Uric Acid Is Associated with Poor Outcome in Black Africans in the Acute Phase of Stroke
Table 4
Independent predictors of poor functional outcome within 3 months post stroke.
| | Predictors | Good outcome | Poor outcome | Unadjusted OR (95% CI) | value | Adjusted OR (95% CI) | value |
| | Age > 45 years | 185 (60.5) | 13 (24.1) | 2.063 (1.061–4.010) | 0.030 | 2.306 (0.966–5.508) | 0.060 | | Male gender | 132 (64.1) | 74 (35.4) | 0.878 (0.571–1.352) | 0.555 | — | — | | Unemployed | 123 (68.0) | 58(32.0) | 0.639 (0.416–0.983) | 0.041 | 1.075 (0.593–1.948) | 0.811 | | Unmarried (single) | 62(68.1) | 29 (31.9) | 0.731(0.441–1.210) | 0.222 | — | — | | No health insurance | 67 (67.7) | 32 (32.3) | 0.745 (0.457–1.214) | 0.236 | — | — | | HTN | 212 (61.8) | 131(38.2) | 2.884 (0.813–10.226) | 0.087 | 2.860 (0.670–12.211) | 0.156 | | DM | 66 (59.5) | 45 (40.5) | 1.226 (0.775–1.940) | 0.385 | — | — | | Smoking | 40 (57.1) | 30 (42.9) | 1.341 (0.789–2.281) | 0.277 | — | — | | Alcohol | 95 (62.9) | 56 (37.1) | 0.990 (0.642–1.527) | 0.964 | — | — | | Dyslipidemia | 175 (61.4) | 110 (38.6) | 1.336 (0.778–2.294) | 0.293 | — | — | | Obesity | 69 (61.1) | 44(38.9) | 1.112 (0.703–1.759) | 0.649 | — | — | | METS | 56 (60.2) | 37 (39.8) | 1.158 (0.713–1.880) | 0.553 | — | — | | CAD/IHD | 16 (69.6) | 7 (30.4) | 0.723 (0.290–1.806) | 0.486 | — | — | | AFIB | 20 (58.8) | 14 (41.2) | 1.202 (0.585–2.467) | 0.616 | — | — | | Cardiopathy | 25 (69.4) | 11 (30.6) | 0.719 (0.342–1.512) | 0.383 | — | — | | Valvulopathy | 14(70.0) | 6 (30.0) | 0.710 (0.266–1.894) | 0.492 | — | — | | Recurrent stroke | 32 (45.1) | 39 (54.9) | 2.488 (1.468–4.220) | 0.001 | 2.566 (1.247–5.280) | 0.010 | | CKD | 11 (64.7) | 6 (35.3) | 0.916 (0.331–2.537) | 0.866 | — | — | | Hemorrhagic stroke | 63 (60.6) | 41 (39.4) | 1.141 (0.714–1,822) | 0.582 | — | — | | SBP > 140 mmHg | 174 (63.0) | 102 (37.0) | 0.953 (0.576–1.576) | 0.850 | — | — | | DBP > 90 mmHg | 142 (62.6) | 85 (37.4) | 1.026 (0.659–1.598) | 0.909 | — | — | | Hyperglycemia | 59 (55.1) | 48 (44.9) | 1.580 (0.996–2.506) | 0.051 | 1.253 (0.670–0.670) | 0.480 | | High LDLc | 165 (61.1) | 105 (38.9) | 1.339 (0.808–2.219) | 0.257 | — | — | | Low HDLc | 129 (61.4) | 81 (38.6) | 1.149 (0.744–1.776) | 0.531 | — | — | | High TC | 106 (62.4) | 64 (37.6) | 1.035 (0.675–1.588) | 0.875 | — | — | | High TG | 45 (64.3) | 25 (35.7) | 0.823 (0.536–1.589) | 0.771 | — | — | | Hyperuricemia | 69 (46.6) | 79 (53.4) | 3.268 (2.093–5.104) | <0.001 | 2.482 (1.399–4.404) | 0.002 | | GCS < 9 | 1 (12.5) | 7 (87.5) | 12.402 (1.509–101.943) | 0.005 | 4.306 (0.439–42.263) | 0.210 | | NIHSS > 14 | 18 (30.0) | 42 (70.0) | 5.275 (2.883–9.653) | <0.001 | 1.369 (0.657–2.854) | 0.402 | | mRS > 2 | 67 (36.4) | 117 (63.6) | 16.333 (9.114–29.269) | <0.001 | 14.639 (7.591–28.232) | <0.001 | | Complications | 53 (49.1) | 55 (50.9) | 2.273 (1.432–3.606) | <0.001 | 1.033 (0.552–1.936) | 0.919 | | High urea | 40 (50.0) | 40 (50.0) | 1.968 (1,189–3.257) | 0.008 | 1.037 (0.532–2.020) | 0.916 | | High creatinine | 56 (58.9) | 39 (41.1) | 1.239 (0.767–2.002) | 0.381 | — | — |
|
|
METS: metabolic syndrome; AFIB: atrial fibrillation; CKD: chronic kidney disease; CAD/IHD: coronary artery/ischemic heart disease.
|
